* Primary: To compare parenteral AC and ROC concentrations administered as 2 g 12-hourly in plasma/CSF of adults with CABM.
Male and female patients [greater than or equal to]18 years of age were eligible if they had confirmed CABM. Patients were excluded if: (i) they had received ceftriaxone <48 hours before admission; (ii) a second antibiotic (except vancomycin) was anticipated to be required; (iii) there was hypersensitivity to [beta]-lactam antibiotics; (iv) there was any concurrent systemic disease, other than HIV/AIDS; (v) there was severe renal impairment (creatinine clearance <30 ml/min); (vi) the pathogen was resistant to ceftriaxone; (vii) foreign bodies or anatomical defects that predisposed patients to meningitis were present; (viii) the meningitis was mycobacterial, viral, fungal or parasitic; or (ix) the patient was pregnant.
Laboratory confirmation of CABM remains a challenge due to the fastidious nature of many of the organisms; as a result negative cultures are common.
As a complement to the theory guide published as volume one, this study aid provides 2,000 multiple choice questions for practice and self-assessment before taking the certified associate business manager (CABM
El consumo de alimento de balaceado en materia seca (CABMS) se determino diariamente de acuerdo a los tratamientos en estudio mediante la diferencia entre las cantidades de alimento ofrecido y residuo (g).
Los mayores CABMS (P<0.01) se registraron en los tratamientos T0, T2, T3, y T1 (48.34; 45.85; 45.16 y 44.16 g MS animal-1 d-1, respectivamente).
En esta investigacion el consumo de balanceado fue inferior a lo reportado por Forte y Fernandez (1999), quienes al utilizar la morera (Morus alba) en la alimentacion de cuyes en crecimiento evaluaron los siguientes tratamientos: T1 = 30 g concentrado + 50 g forraje morera; T2 = 20 g concentrado + 100 g forraje morera y T3 = 15 g concentrado + 150 g forraje morera, con valores de CABMS (53.00, 52.60 y 52.60 g [animal.sup.-1] [d.sup.-1], respectivamente).